Tracking 1000 cancer patients to see if targeted drug delivery helps them live longer

NCT ID NCT06805461

Recruiting now Knowledge-focused Sponsor: RenovoRx Source: ClinicalTrials.gov ↗

Summary

This study is creating a registry to track the safety and long-term survival of cancer patients who receive a specific type of targeted treatment. It will follow up to 1000 adults with solid tumors who have their chemotherapy delivered directly to the tumor using a special catheter called the RenovoCath®. The goal is to collect real-world information on how well the treatment works and what side effects patients experience over time.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for SOLID TUMORS are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Show contact details

Study contacts

Contact

Phone: •••-•••-•••• Email: •••••@•••••
Contact

Phone: •••-•••-•••• Email: •••••@•••••

Locations

Baptist Health South Florida
RECRUITING

Coral Gables, Florida, 33143, United States

Contact
The University of Vermont Medical Center
RECRUITING

Burlington, Vermont, 05401, United States

Contact
University of Pennsylvania Medical Center
RECRUITING

Pittsburgh, Pennsylvania, 15213, United States

Contact

Conditions

Explore the condition pages connected to this study.

SOLID TUMORS